UK and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.
It cannot be seen, smelled or tasted, and people are exposed by breathing radon in air when it comes in through gaps and cracks in their homes. It is the second-leading cause of lung cancer after tobacco smoking.
Across the country, a lot of health care-related research has been paused as people are asked to stay home and maintain social distancing. However, there’s some good news: many clinical trials are still underway.
A new book of essays by young Kentucky students seeks to inform, inspire, motivate and uplift the reader through personal cancer stories and cancer prevention initiatives.
A new study led by UK Markey Cancer Center researchers suggests that implementing cancer education curricula in middle and high schools may improve cancer literacy in Kentuckians and ultimately help reduce cancer rates.
The UK College of Public Health, in coordination with UofL and the Kentucky Cancer Consortium, have created a worksite intervention on lung cancer, which targets work sites with predominantly male employees in eight rural and medically underserved counties in southern Kentucky.
Nearly 40 percent of women diagnosed with breast cancer will require a mastectomy. For those patients, breast reconstruction surgery is a valuable part of breast cancer care as studies show it improves quality of life, self-esteem and sexuality.
Ten years ago, UK administrators, students, faculty and staff made the decision to become a tobacco-free campus. Since then, the university has become a healthier place to live, work and learn.
This new study will involve public health partners throughout Appalachia, a geographically unique and underserved area that spans 54 counties in Kentucky and 32 counties in Ohio.
